Not applicableStudy completedNCT00274794What this trial is testingVP and G-CSF With or Without Rituximab in Autologous Peripheral Stem Cell Transplant For NHLWho this might be right forLymphoma The Cleveland Clinic 55
Testing effectiveness (Phase 2)Active Not RecruitingNCT02339922What this trial is testingIxazomib Citrate and Rituximab in Treating Patients With Indolent B-cell Non-Hodgkin LymphomaWho this might be right forChronic Lymphocytic LeukemiaFollicular LymphomaLymphoplasmacytic Lymphoma+6 more University of Washington 33
Early research (Phase 1)Study completedNCT00003970What this trial is testingGenetic Testing Plus Irinotecan in Treating Patients With Solid Tumors or LymphomaWho this might be right forAIDS-related Peripheral/Systemic LymphomaAIDS-related Primary CNS LymphomaAnaplastic Large Cell Lymphoma+56 more National Cancer Institute (NCI) 60
Testing effectiveness (Phase 2)Ended earlyNCT05296525What this trial is testingEvaluation of Safety and Efficacy of Allo GDA-201 Natural Killer (NK) Cells in Patients With Relapsed/Refractory B Cell NHLWho this might be right forNon-Hodgkin Lymphoma Gamida Cell ltd 13
Testing effectiveness (Phase 2)Study completedNCT01290120What this trial is testingChemotherapy Plus Rituximab Combination for Adult Lymphoblastic Leukemia (B-ALL) and Burkitt's Non-Hodgkin LymphomaWho this might be right forBurkitt LymphomaB-ALL Northern Italy Leukemia Group 182
Post-approval studies (Phase 4)UnknownNCT02996617What this trial is testingPEG-rhG-CSF in Patients With Non-Hodgkin Lymphoma Receiving Chemotherapy to Prevent NeutropeniaWho this might be right forLymphoma,Non-Hodgkin Shandong Provincial Hospital 240
Testing effectiveness (Phase 2)WithdrawnNCT01238146What this trial is testingObatoclax Mesylate, Rituximab, and Bendamustine Hydrochloride in Treating Patients With Relapsed or Refractory Non-Hodgkin LymphomaWho this might be right forExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueNodal Marginal Zone B-cell LymphomaRecurrent Grade 1 Follicular Lymphoma+4 more National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Ended earlyNCT01998035What this trial is testingRomidepsin Plus Oral 5-Azacitidine in Relapsed/Refractory Lymphoid MalignanciesWho this might be right forLymphoid MalignanciesLymphomaHodgkin Lymphoma+1 more Columbia University 58
Testing effectiveness (Phase 2)Study completedNCT00002725What this trial is testingBryostatin-1 in Treating Patients With Recurrent Non-Hodgkin's LymphomaWho this might be right forLymphoma National Cancer Institute (NCI) 35
Not applicableUnknownNCT05797948What this trial is testingGZL Sequential CD19/CD22 CAR-T in Relapsed or Refractory B-cell Non-Hodgkin LymphomaWho this might be right forRelapsed or Refractory B-cell Non-Hodgkin Lymphoma The First Affiliated Hospital of Soochow University 20
Testing effectiveness (Phase 2)Looking for participantsNCT05890352What this trial is testingStudy Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to TreatmentWho this might be right forGrade 3b Follicular LymphomaHigh Grade B-Cell LymphomaHigh Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements+3 more SWOG Cancer Research Network 227
Early research (Phase 1)Study completedNCT00068315What this trial is testingBortezomib and Fludarabine With or Without Rituximab in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma or Chronic Lymphocytic LeukemiaWho this might be right forExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueHematopoietic/Lymphoid CancerNodal Marginal Zone B-cell Lymphoma+9 more National Cancer Institute (NCI) 18
Early research (Phase 1)Study completedNCT01254578What this trial is testingLenalidomide After Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic CancersWho this might be right forAdult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11+39 more National Cancer Institute (NCI) 17
Early research (Phase 1)Study completedNCT00002625What this trial is testingTopotecan and Radiation Therapy in Treating Patients With Solid Tumors or LymphomaWho this might be right forEsophageal CancerLung CancerLymphoma National Cancer Institute (NCI) 5
Early research (Phase 1)Study completedNCT00003993What this trial is testingBryostatin 1 and Interleukin-2 in Treating Patients With Refractory Solid Tumors or LymphomaWho this might be right forLymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific National Institute on Aging (NIA) 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT05025800What this trial is testingALX148, Rituximab and Lenalidomide for the Treatment of Indolent and Aggressive B-cell Non-Hodgkin LymphomaWho this might be right forAggressive B-Cell Non-Hodgkin LymphomaAnn Arbor Stage III Grade 2 Follicular LymphomaAnn Arbor Stage III Grade 3 Follicular Lymphoma+17 more M.D. Anderson Cancer Center 47
Testing effectiveness (Phase 2)Ended earlyNCT03207867What this trial is testingNIR178 in Combination With PDR001 in Patients With Solid Tumors and Non-Hodgkin LymphomaWho this might be right forNSCLC, Non Small Cell Lung CancerRCC, Renal Cell CancerPancreatic Cancer+7 more Novartis Pharmaceuticals 315
Testing effectiveness (Phase 2)Study completedNCT01613300What this trial is testingStudy of OFATUMUMAB as Part of the Scheme of Reduced Intensity Conditioning in High Risk Non-Hodgkin Lymphoma B PatientsWho this might be right forB-Cell Lymphomas Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea 33
Early research (Phase 1)Looking for participantsNCT06734871What this trial is testingA Clinical Study Exploring CT1190B in the Treatment of Patients with Relapsed/refractory B-cell Non-Hodgkin LymphomaWho this might be right forB-Cell Non-Hodgkin Lymphoma Aibin Liang，MD，Ph.D. 24
Large-scale testing (Phase 3)Active Not RecruitingNCT03206671What this trial is testingTreatment Protocol of the NHL-BFM and the NOPHO Study Groups for Mature Aggressive B-cell Lymphoma and Leukemia in Children and AdolescentsWho this might be right forMature B-cell Non-Hodgkin Lymphoma University Hospital Muenster 650